Drugs — Product or service?

Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing

Volumn 6, Issue 4, 2006, Pages 282-286

  Møldrup, Claus ^a   Kruse, Poul R ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

drugs; medicines; product; service; third patent

Indexed keywords

EID: 84990328579     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5050053     Document Type: Article

References (19)

1. NN Anonymous contribution (1922). Farmaceutisk Tidende 32, 573–575.
2. Gram H. C. (1929). Lægebog for Hjemmet, Nordisk forlag, K⊘benhavn.
3. Marsh J. (2005). Pharmaceutical branding, Logo Design Works., http://www.logodesignworks.com/articles?brand_articles/win_in_world_of_pharmaceutica_branding.htm(accessed 9th October, 2006).
4. Greenslit N. (2002). Pharmaceutical branding: Identity, individuality, and illness. Mol. Intervent. 2, 342–345.
5. Colorcon Inc (2006). Tablet branding: Imaging benefits Colorcon Inc., http://www.colorcon.com/best/b01_img_benefits.html (accessed 3rd August, 2006).
6. Krishna S. Balas E. A. Boren S. A. Maglaveras N. (2002). Patient acceptance of educational voice messages: A review of controlled clinical studies. Method. Inform. Med. 41(5), 360–369.
7. Lachowsky M. Levy T. R. (2002). Improving compliance in oral contraception: ‘The reminder card’. Eur. J. Contracept. Reprod. Health Care 7(4), 210–215.
8. Van E. M. Tsang S. Wensing M. De-Smet P. A. Grol R. P. (2003). Interventions to improve medication compliance in older patients living in the community: A systematic review of the literature. Drugs Aging 20(3), 229–240.
9. Szilagyi P. G. Bordley C. Vann J. C. Chelminski A. Kraus R. M. Margolis P. A. Rodewald L. E. (2000). Effect of patient reminder/recall interventions on immunization rates: A review. J. Am. Med. Assoc. 284(14), 1820–1827.
10. Mayer J. A. Lewis E. C. Slymen D. J. Dullum J. Kurata H. Holbrook A. Elder J. P. Williams S. J. (2000). Patient reminder letters to promote annual mammograms: A randomized controlled trial. Prevent. Med. 31(4), 315–322.
11. Rosser W. W. Hutchison B. G. McDowell I. Newell C. (1992). Use of reminders to increase compliance with tetanus booster vaccination. Can. Med. Assoc. J. 146(6), 911–917.
12. Raynor D. K. Booth T. G. Blenkinsopp A. (1993). Effects of computer generated reminder charts on patients’ compliance with drug regimens. BMJ 306(6886), 1158–1161.
13. Vilella A. Bayas J. M. Diaz M. T. Guinovart C. Diez C. Simo D. Munoz A. Cerezo J. (2004). The role of mobile phones in improving vaccination rates in travelers. Prevent. Med. 38(4), 503–509.
14. Szilagyi P. Vann J. J. Bordley C. Targonski P. V. Poland G. A. (2003). Review: Patient reminder or recall systems improve immunisation rates. Evidence Based Med. 8(4), 124.
15. Bengtsson F. (2004). Therapeutic drug monitoring of psychotropic drugs. TDM ‘nouveau’, Ther. Drug Monitor. 26, 145–151.
16. M⊘ldrup C. (2005). No cure no pay. BMJ 167, 2150–2153.
17. M⊘ldrup C. (2005). The prospects and bioethical dimensions of expanding the meaning of pharmacogenomics to compass individualized pharmacotherapy. Personal. Med. 2, 168–169.
18. Novartis (2006) BP success Zone. Novartis. www.bpsuccesszone.com (accessed 3rd August, 2006).
19. Lungen M. Gerber A (2005). Drugs: Product or service?. BMJ Publishing Group Ltd. http://bmj.bmjjournals.com/cgi/eletters/330/7502/1262#109270 (accessed 3rd August, 2006).